Table 2 Baseline characteristics of participants in each group divided by outcome
Variables | Total (n = 12,299) | without incident CAD (n = 11,126) | with incident CAD (n = 1173) | P-value |
|---|---|---|---|---|
UCR_GROUP | 2 ± 0.32 | 2 ± 0.32 | 2.03 ± 0.33 | 0.004 |
sex(men) | 8,439 (68.62) | 7624 (68.52) | 815 (69.48) | 0.524 |
age | 52.57 ± 12.16 | 52.07 ± 12.21 | 57.37 ± 10.59 |  < 0.001 |
Body Mass Index (BMI) | 26.32 ± 3.7 | 26.3 ± 3.72 | 26.53 ± 3.48 | 0.048 |
Waist | 88.93 ± 10.43 | 88.84 ± 10.49 | 89.86 ± 9.78 | 0.001 |
Waist-To-Hip Ratio (WHR) | 0.88 ± 0.06 | 0.88 ± 0.06 | 0.89 ± 0.06 |  < 0.001 |
Systolic Blood Pressure (SBP) | 129.84 ± 6.87 | 129.55 ± 16.86 | 132.63 ± 16.68 |  < 0.001 |
Diastolic Blood Pressure (DBP) | 83.42 ± 11.37 | 83.3 ± 11.43 | 84.58 ± 10.69 |  < 0.001 |
White Blood Cell Count (WBC) | 6.79 ± 1.73 | 6.79 ± 1.74 | 6.75 ± 1.57 | 0.382 |
Neutrophil Count (NEUT) | 3.98 ± 1.3 | 3.98 ± 1.31 | 3.95 ± 1.2 | 0.468 |
Lymphocyte Count (LYM) | 2.25 ± 0.73 | 2.25 ± 0.74 | 2.21 ± 0.64 | 0.047 |
Fasting Plasma Glucose (FPG) | 7.15 ± 2.32 | 7.16 ± 2.33 | 7.02 ± 2.23 | 0.04 |
Fasting Plasma Glucose Follow (FPG_F) | 7.05 ± 2.4 | 7.05 ± 2.4 | 7.02 ± 2.34 | 0.712 |
Total Cholesterol (TC) | 5.11 ± 1.01 | 5.11 ± 1.01 | 5.16 ± 1.01 | 0.098 |
Low-Density Lipoprotein Cholesterol (LDL-C) | 2.98 ± 0.86 | 2.98 ± 0.85 | 3.03 ± 0.88 | 0.042 |
High-Density Lipoprotein Cholesterol (HDL-C) | 1.19 ± 0.29 | 1.2 ± 0.29 | 1.16 ± 0.28 |  < 0.001 |
Triglyceride (TG) | 2.21 ± 2.39 | 2.21 ± 2.41 | 2.26 ± 2.17 | 0.444 |
Estimated Glomerular Filtration Rate (eGFR) | 105.05 ± 23.72 | 104.87 ± 23.37 | 106.67 ± 26.81 | 0.013 |
Triglyceride glucose (TyG) | 2.51 ± 0.8 | 2.44 ± 0.81 | 2.58 ± 0.77 | 0.015 |